AKEBIA THERAPEUTICS, INC. (AKBA)
Clinical trial NCT07086755 updates: 1. completion date: 2026-07-01 → 2031-05-31 2. primary completion date: 2026-07-01 → 2031-05-31 3. collaborators added: Akebia Therapeutics 4. collaborators removed: Akebia Therapeutics Inc.
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical